MinichMacGregor Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-714
Closed -$48.3K 451
2022
Q4
$48.3K Buy
+714
New +$41.9K 0.02% 182
2016
Q2
Sell
-700
Closed -$18K 462
2016
Q1
$18K Buy
+700
New +$18.8K 0.02% 187

Other funds holding NVO

MinichMacGregor Wealth Management's NVO Position: Q1 2023 in Review

MinichMacGregor Wealth Management sold out of Novo Nordisk (NVO) in Q1 2023, closing a stake of 714 shares — an estimated $48.3K sold.

MinichMacGregor Wealth Management first reported a position in NVO in Q1 2016 and held it in 2 quarters. The position peaked at $48.3K in Q4 2022. 1,145 funds tracked by Wall St. Rank hold NVO as of Q1 2023.

  • MinichMacGregor Wealth Management reported no remaining Novo Nordisk position as of Q1 2023 after selling out during the quarter.
  • MinichMacGregor Wealth Management sold 714 Novo Nordisk shares in Q1 2023, an estimated $48.3K.
  • MinichMacGregor Wealth Management first reported a position in Novo Nordisk in Q1 2016 and held it in 2 quarters.
  • MinichMacGregor Wealth Management's Novo Nordisk position peaked at $48.3K in Q4 2022.
  • 1,145 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2023.

Based on MinichMacGregor Wealth Management's 13F filing for Q1 2023, filed 19 Apr 2023.